CLOVER HEALTH INVESTMENTS, CORP.CLOVEarnings & Financial Report
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
CLOV Q4 FY2025 Key Financial Metrics
Revenue
$487.7M
Gross Profit
N/A
Operating Profit
$-49.3M
Net Profit
$-49.3M
Gross Margin
N/A
Operating Margin
-10.1%
Net Margin
-10.1%
YoY Growth
44.7%
CLOVER HEALTH INVESTMENTS, CORP. Q4 FY2025 Financial Summary
CLOVER HEALTH INVESTMENTS, CORP. reported revenue of $487.7M (up 44.7% YoY) for Q4 FY2025, with a net profit of $-49.3M (down 123.2% YoY) (-10.1% margin).
Key Financial Metrics
| Total Revenue | $487.7M |
|---|---|
| Net Profit | $-49.3M |
| Gross Margin | N/A |
| Operating Margin | -10.1% |
| Report Period | Q4 FY2025 |
CLOVER HEALTH INVESTMENTS, CORP. Annual Revenue by Year
CLOVER HEALTH INVESTMENTS, CORP. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.9B).
CLOVER HEALTH INVESTMENTS, CORP. Quarterly Revenue & Net Profit History
CLOVER HEALTH INVESTMENTS, CORP. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $487.7M | +44.7% | $-49.3M | -10.1% |
| Q3 FY2025 | $496.6M | +50.1% | $-24.4M | -4.9% |
| Q2 FY2025 | $477.6M | +34.1% | $-10.6M | -2.2% |
| Q1 FY2025 | $462.3M | +33.3% | $-1.3M | -0.3% |
| Q4 FY2024 | $337.0M | +7.9% | $-22.1M | -6.6% |
| Q3 FY2024 | $331.0M | +8.2% | $-9.2M | -2.8% |
| Q2 FY2024 | $356.3M | +11.3% | $7.4M | 2.1% |
| Q1 FY2024 | $346.9M | +7.7% | $-19.2M | -5.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $346.9M | $356.3M | $331.0M | $337.0M | $462.3M | $477.6M | $496.6M | $487.7M |
| YoY Growth | 7.7% | 11.3% | 8.2% | 7.9% | 33.3% | 34.1% | 50.1% | 44.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $671.8M | $674.2M | $653.0M | $580.7M | $583.7M | $575.0M | $559.7M | $541.0M |
| Liabilities | $379.3M | $349.3M | $310.8M | $239.6M | $247.6M | $230.8M | $218.7M | $232.3M |
| Equity | $292.5M | $324.9M | $342.2M | $341.1M | $336.1M | $344.2M | $340.9M | $308.7M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $25.9M | $44.8M | $50.0M | $34.8M | $-16.3M | $5.4M | $12.1M | $-66.9M |